Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 7/20 | 0.56 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.52 |
| ▸ | LAP3 | P28838 | 2/20 | 0.45 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.42 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.41 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL9063703 | 0.95 | FDPS (0.56) | FDPSDNM1LAP3GGPS1SMPD1 | |
| Phosphoric Acid SCHEMBL6909609 | 0.95 | FDPS (0.56) | FDPSDNM1LAP3GGPS1SMPD1 | |
| Phosphoric Acid SCHEMBL10530594 | 0.93 | DNM1 (0.65) | FDPSDNM1LAP3GGPS1SMPD1 | |
| Methyl Phosphonate SCHEMBL7180323 | 0.93 | FDPS (0.54) | FDPSDNM1LAP3GGPS1SMPD1 | |
| Phosphoric Acid SCHEMBL9063702 | 0.92 | DNM1 (0.60) | FDPSDNM1LAP3GGPS1 | |
| Phosphoric Acid SCHEMBL266936 | 0.92 | DNM1 (0.60) | FDPSDNM1LAP3GGPS1 | |
| Phosphoric Acid SCHEMBL10530590 | 0.91 | DNM1 (0.62) | FDPSDNM1LAP3GGPS1SMPD1 | |
| Phosphoric Acid SCHEMBL7172651 | 0.90 | DNM1 (0.57) | FDPSDNM1LAP3GGPS1 | |
| Phosphoric Acid SCHEMBL7178325 | 0.90 | DNM1 (0.57) | FDPSDNM1LAP3GGPS1 | |
| Phosphoric Acid SCHEMBL28592517 | 0.89 | DNM1 (0.65) | FDPSDNM1LAP3GGPS1SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3135677-B1 | ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING SAME, AND USE FOR SAME | JX NIPPON OIL & ENERGY CORP (JP) | 2018-10-10 | — | — | EP | disclosed |
| US-9695186-B2 | Alicyclic diepoxy compound having bis-spironorbornane structure, method for producing the same, and use thereof | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2017-07-04 | — | — | US | disclosed |
| EP-3135677-A1 | ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING SAME, AND USE FOR SAME | JX Nippon Oil & Energy Corporation (JP) | 2017-03-01 | — | — | EP | disclosed |
| US-20170044179-A1 | ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE THEREOF | JX NIPPON OIL & ENERGY CORPORATION (JP) | 2017-02-16 | — | — | US | disclosed |
| US-8734744-B2 | Separation of gases | PETROLIAM NASIONAL BERHAD (MY) | 2014-05-27 | — | — | US | disclosed |
| US-20130071309-A1 | SEPARATION OF GASES | PETROLIAM NASIONAL BERHAD (MY) | 2013-03-21 | — | — | US | disclosed |
| US-20040147655-A1 | Aromatic polycarbonate resin composition | TEIJIN LIMITED (JP) | 2004-07-29 | — | — | US | disclosed |
| US-20030195329-A1 | Aromatic polycarbonate, composition thereof , and use | TEIJIN LIMITED (JP) | 2003-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130071309-A1 | SEPARATION OF GASES | EPCAM, CA9, ALKBH2 | FDPS 1879/4885DNM1 4671/4885LAP3 1817/4885 |
| US-20170044179-A1 | ALICYCLIC DIEPOXY COMPOUND HAVING BIS-SPIRONORBORNANE STRUCTURE, METHOD FOR PRODUCING THE SAME, AND USE THEREOF | DHCR7, HSD17B7, CYP17A1 | FDPS 32/4885DNM1 834/4885LAP3 4424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.